THE LAST DAYS OF A FAMOUS MIME "REPETITION AND SPIRAL

Authors

  • Aline Amsberg de Almeida

Keywords:

Peter Carey, Mímica, Terror.

Abstract

The short story “The Last Days of a Famous Mime”, written by the Australian Peter
Carey and published in 1979, tells the story of a mime specialized in miming terror. I do the
analysis of the story heading to the idea of a culture of terror that is growing in our contemporary
society, as well as, the idea of the mime as threat established in and by the colonization and
persists up to the post-colonial era, being visible in the literary production of this period, as it is
Peter Carey’s literature. For this, I use Jacques Derrida’s, Jacques Gleyse’s Homi Bhabha’s and
Zygmunt Bauman’s thoughts.

Downloads

Download data is not yet available.

Downloads

Published

29-12-2009

How to Cite

AMSBERG DE ALMEIDA, A. THE LAST DAYS OF A FAMOUS MIME "REPETITION AND SPIRAL. Travessias, Cascavel, v. 3, n. 3, 2009. Disponível em: https://e-revista.unioeste.br/index.php/travessias/article/view/3444. Acesso em: 17 jul. 2024.

Issue

Vol. 3 No. 3 (2009)

Section

CULTURA

License

Creative Copyright Notice

Policy for Free Access Journals

Authors who publish in this journal agree to the following terms:

1. Authors keep the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the  Creative Commons Attribution License, which allows sharing the trial with acknowledgment of authorship and initial publication in this journal.

2. Authors are authorized to take additional contracts separately, for non-exclusive distribution of the work version, published in this journal (eg publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.

3. Authors are allowed and encouraged to publish and distribute their work online (eg in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes, as well as increase both impact and citation of the published trial (See The Effect of Free Access).

 

 

Creative Commons License

This work is licensed under a Creative Commons Attribution–NonCommercial-shareaswell 4.0 International License, which allows you to share, copy, distribute, display, reproduce, completely or part of the work, since there is no commercial purpose, and authors and source are cited.